The possible role of zinc and metallothionein in the liver on the therapeutic effect of IFN-α to hepatitis C patients
✍ Scribed by Takeaki Nagamine; Hitoshi Takagi; Yoshiaki Hashimoto; Hisashi Takayama; Ryuya Shimoda; Naruo Nomura; Keiji Suzuki; Masatomo Mori; Katsuyuki Nakajima
- Publisher
- Humana Press Inc
- Year
- 1997
- Tongue
- English
- Weight
- 973 KB
- Volume
- 58
- Category
- Article
- ISSN
- 0163-4984
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
The meta-analysis of propranolol compared with endoscopic variceal ligation for primary prophylaxis of variceal bleeding by Imperiale and Chalasani 1 favors pharmacotherapy despite the fact that "none of the trials measured the hemodynamic response to propranolol." "Blind beta blockade" is the admin
BACKGROUND. Interferon (IFN) has been reported to have beneficial long term effects that reduce the occurrence of hepatocellular carcinoma (HCC), even in patients who do not have complete responses to IFN. The authors evaluated the effect of retreatment with IFN-␣ on the long term prognoses of those
Of 74 patients who were infected with hepatitis C virus (HCV) and received interferon, 12 (16%) were positive for RNA of GB virus C (GBV-C). RNA of GBV-C was determined in sera from the co-infected patients retrospectively, and the effect of interferon on GBV-C was compared with that on HCV in them.
## Abstract Sera obtained from 381 patients with chronic liver disease from four cities within the USSR were studied for HBV, HDV, and HCV markers of infection. Anti‐HCV activity was detected in 41.2% of non‐A, non‐B cases. The etiological distribution of chronic hepatitis in Moscow and Dushanbe wa